These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25065618)

  • 1. Hepatic expression of miR-122, miR-126, miR-136 and miR-181a and their correlation to histopathological and clinical characteristics of patients with hepatitis C.
    Boštjančič E; Bandelj E; Luzar B; Poljak M; Glavač D
    J Viral Hepat; 2015 Feb; 22(2):146-57. PubMed ID: 25065618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased hepatic expression of miRNA-122 in patients infected with HCV genotype 3.
    Oliveira KG; Malta FM; Nastri AC; Widman A; Faria PL; Santana RA; Alves VA; Carrilho FJ; Pinho JR
    Med Microbiol Immunol; 2016 Apr; 205(2):111-7. PubMed ID: 26272127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translation efficiencies of the 5'-untranslated region of genotypes 1a and 3a in hepatitis C infected patients.
    Motazakker M; Preikschat P; Elliott J; Smith CA; Mills PR; Oien K; Spence E; Elliott RM; McCruden EA
    J Med Virol; 2007 Mar; 79(3):259-69. PubMed ID: 17245719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA profile before and after antiviral therapy in liver transplant recipients for hepatitis C virus cirrhosis.
    Gelley F; Zadori G; Nemes B; Fassan M; Lendvai G; Sarvary E; Doros A; Gerlei Z; Nagy P; Schaff Z; Kiss A
    J Gastroenterol Hepatol; 2014 Jan; 29(1):121-7. PubMed ID: 24033414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.
    Zhang S; Ouyang X; Jiang X; Gu D; Lin Y; Kong SK; Xie W
    Int J Med Sci; 2015; 12(7):590-8. PubMed ID: 26283876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology.
    Zeuzem S; Franke A; Lee JH; Herrmann G; Ruster B; Roth WK
    Hepatology; 1996 Nov; 24(5):1003-9. PubMed ID: 8903367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting miRNAs to treat Hepatitis C Virus infections and liver pathology: Inhibiting the virus and altering the host.
    Thibault PA; Wilson JA
    Pharmacol Res; 2013 Sep; 75():48-59. PubMed ID: 23541631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased miR-16 expression induced by hepatitis C virus infection promotes liver fibrosis through downregulation of hepatocyte growth factor and Smad7.
    Zhu B; Wei XX; Wang TB; Zhou YC; Liu AM; Zhang GW
    Arch Virol; 2015 Aug; 160(8):2043-50. PubMed ID: 26071245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA expression profiles in liver grafts of HCV and HIV/HCV-infected recipients, 6 months after liver transplantation.
    Bulfoni M; Pravisani R; Dalla E; Cesselli D; Hidaka M; Di Loreto C; Eguchi S; Baccarani U
    J Med Virol; 2021 Aug; 93(8):4992-5000. PubMed ID: 33818800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma.
    Ura S; Honda M; Yamashita T; Ueda T; Takatori H; Nishino R; Sunakozaka H; Sakai Y; Horimoto K; Kaneko S
    Hepatology; 2009 Apr; 49(4):1098-112. PubMed ID: 19173277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.
    Sebastiani G; Vario A; Ferrari A; Pistis R; Noventa F; Alberti A
    J Viral Hepat; 2006 Mar; 13(3):199-205. PubMed ID: 16475996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the hepatitis C virus genome replication by miR-199a.
    Murakami Y; Aly HH; Tajima A; Inoue I; Shimotohno K
    J Hepatol; 2009 Mar; 50(3):453-60. PubMed ID: 19144437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype.
    Mihm S; Fayyazi A; Hartmann H; Ramadori G
    Hepatology; 1997 Mar; 25(3):735-9. PubMed ID: 9049227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No increase in the expression of key unfolded protein response genes in HCV genotype 3 patients with severe steatosis.
    Congiu M; Ryan MC; Desmond PV
    Virus Res; 2011 Sep; 160(1-2):420-3. PubMed ID: 21741418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of biochemical markers and HCV RNA titers with fibrosis stages and grades in chronic HCV-3a patients.
    Shahid M; Idrees M; Nasir B; Raja AJ; Raza SM; Amin I; Rasul A; Tayyab GU
    Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):788-94. PubMed ID: 24781355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between serum adiponectin and steatosis in patients with chronic hepatitis C genotype-4.
    Ashour E; Samy N; Sayed M; Imam A
    Clin Lab; 2010; 56(3-4):103-10. PubMed ID: 20476641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].
    Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D
    Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic expression of hepatitis C virus RNA in chronic hepatitis C: a study by in situ reverse-transcription polymerase chain reaction.
    Lau GK; Davis GL; Wu SP; Gish RG; Balart LA; Lau JY
    Hepatology; 1996 Jun; 23(6):1318-23. PubMed ID: 8675145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of steatosis and inflammation on liver fibrosis in chronic hepatitis C.
    Nieminen U; Arkkila PE; Kärkkäinen P; Färkkilä MA
    Liver Int; 2009 Feb; 29(2):153-8. PubMed ID: 18482270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood mononuclear cells microRNA predicts treatment outcome of hepatitis C virus genotype 1 infection.
    Hsi E; Huang CF; Dai CY; Juo SH; Chou WW; Huang JF; Yeh ML; Lin ZY; Chen SC; Wang LY; Chuang WL; Yu ML
    Antiviral Res; 2014 May; 105():135-42. PubMed ID: 24637254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.